Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by BayStreetWildon Jun 13, 2023 11:28am
92 Views
Post# 35493726

RE:RE:RE:RE:RE:RE:RE:Low Share Price Because...

RE:RE:RE:RE:RE:RE:RE:Low Share Price Because...Is your thinking... they saw the company spent 20 years and  $ 100+ million to get to where they are today (having seen the entire dataset from the last trial) so they said.. oh we will give them $5 million but when they get to interim enrolment and spend another $ 40 million to get there... we will give them $ 20 million?
<< Previous
Bullboard Posts
Next >>